(Q36003453)

11 August 2017

1 reference

title

Penicillamine in rheumatoid arthritis: adverse effects (English)

1 reference

11 August 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

14 May 2022

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

14 May 2022

author name string

H. F. Hill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A156393

14 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=156393

14 May 2022

publication date

1 January 1979

1 reference

full work available at URL

11 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/03009747909108247

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Scandinavian journal of rheumatology. Supplement

14 May 2022

published in

1 reference

11 August 2017

issue

28

1 reference

11 August 2017

page(s)

94-99

1 reference

Penicillamine in rheumatoid disease: a long-term study

11 August 2017

cites work

3

1

180

Day A. T.

1974

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

The British journal of clinical practice

14 May 2022

4

31

5

Dippy J. E

1977

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Goodpasture Syndrome and D-Penicillamine

14 May 2022

5

84

100

Gibson T.

1976

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Letter: Pemphigus induced by D-penicillamine

14 May 2022

6

3

371

Hewitt J.

1975

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Treatment of rheumatoid arthritis with penicillamine

14 May 2022

7

6

361

Hill Hilary F.H

1977

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Annals of the Rheumatic Diseases

14 May 2022

8

37

288

Hill H.

1978

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

14 May 2022

10

1

24

Huskisson E. C

1976

0 references

Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone

11

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Herpetiform pemphigus induced by penicillamine

17 December 2022

14

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Pemphigus foliaceus induced by penicillamine

17 December 2022

15

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Benign mucous-membrane pemphigoid associated with penicillamine treatment

17 December 2022

17

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome

17 December 2022

19

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Pemphigus erythematosus-like rash in a patient on penicillamine

17 December 2022

20

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Penicillamine pemphigus and the nephrotic syndrome occurring simultaneously

17 December 2022

21

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

D-penicillamine in the treatment of rheumatoid arthritis

17 December 2022

22

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold?

17 December 2022

23

1 reference

https://api.crossref.org/works/10.3109/03009747909108247

17 December 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=156393

17 December 2022

1 reference